SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

21.50p
   
  • Change Today:
      1.20p
  • 52 Week High: 26.10p
  • 52 Week Low: 12.25p
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 1,218,617
  • Market Cap: £55.64m
  • Beta: 0.52

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Emily Bertram
Executive Director: Simon Hewitson
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Alyson Margaret Levett

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 21.50p
Change Today 1.20p
% Change 5.91 %
52 Week High 26.10p
52 Week Low 12.25p
Volume 1,218,617
Shares Issued 258.78m
Market Cap £55.64m
Beta 0.52

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 09-Jan-2026

Time Volume / Share Price
17:06 6,000 @ 21.50p
16:29 5,000 @ 21.00p
16:27 50,000 @ 21.00p
16:25 30,000 @ 21.26p
16:23 97,000 @ 21.50p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page